Close Menu
    What's Hot

    Australia slips into unexpected AUD 3.02B trade deficit as exports tum

    July 2, 2026

    Base44 CEO Says the Company Built Its Own LLM to Combat AI-Slop Design

    July 2, 2026

    Franklin Covey forecasts FY2026 revenue of $260M-$267M while maintaining adjusted EBITDA of $28M-$31M (NYSE:FC)

    July 2, 2026
    Facebook X (Twitter) Instagram
    Hot Paths
    • Home
    • News
    • Politics
    • Money
    • Personal Finance
    • Business
    • Economy
    • Investing
    • Markets
      • Stocks
      • Futures & Commodities
      • Crypto
      • Forex
    • Technology
    Facebook X (Twitter) Instagram
    Hot Paths
    Home»Business»Covid lockdown sceptic is frontrunner to lead Trump health agency
    Business

    Covid lockdown sceptic is frontrunner to lead Trump health agency

    Press RoomBy Press RoomNovember 23, 2024No Comments4 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr Email
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Unlock the White House Watch newsletter for free

    Your guide to what the 2024 US election means for Washington and the world

    Stanford University professor and Covid-19 lockdown sceptic Jay Bhattacharya has emerged as the frontrunner to run the National Institutes of Health, according to two people familiar with the matter.

    The nomination of Bhattacharya, who rose to prominence during the pandemic for opposing lockdown restrictions, would put another ally of Robert Kennedy Jr, the vaccine sceptic who is Trump’s pick to run the US health department, in charge of one of the country’s most powerful public health agencies.

    With an annual budget of $48bn, NIH is the biggest government-funded biomedical research agency in the world, providing more than 60,000 grants a year to support medical and scientific research.

    Senior officials within Trump’s transition team have spoken with Bhattacharya, who runs Stanford’s Center on the Demography and Economics of Health and Aging, in recent days, the people said.

    The pick for NIH director is likely to be announced in the coming days but plans may change and another candidate may emerge, the people added.

    Representatives for Trump’s transition team and Kennedy did not immediately respond to requests for comment. Bhattacharya could also not be reached for comment.

    Late on Friday, Trump’s transition team announced a flurry of high profile nominations, including Treasury secretary, Labor secretary and three key health official picks.

    Marty Makary, a Johns Hopkins surgeon who opposed the Covid-19 vaccine mandate, was nominated to run the Food and Drug Administration. Physician and former GOP congressman Dave Weldon, who has cast doubts on vaccine safety, was tapped to run the Centers for Disease Control and Prevention.

    Bhattacharya appeared alongside Kennedy at a campaign event during his independent campaign for President, during which he unveiled his running mate Nicole Shanahan.

    Since backing Trump’s bid for presidency in August, Kennedy has been given significant influence over the president’s healthcare policy agenda as part of his “Make American Healthy Again” campaign. Trump’s choice of Fox News medical contributor Janette Nesheiwat was the only one of the health appointees so far not close to Kennedy, the people added.

    Alongside two other professors, Bhattacharya became the face of the “Great Barrington Declaration” during the pandemic, an open letter published in October 2020 opposing widescale lockdowns and instead calling for restrictions focused on at-risk groups, such as elderly individuals. The letter provoked criticism from then-NIH director Francis Collins, who dismissed the authors as “fringe experts”.

    Much of Bhattacharya’s public criticism of the NIH has focused on how Collins and Anthony Fauci — former director of the US National Institute of Allergy and Infectious Diseases, a division of NIH — responded to the pandemic.

    Bhattacharya told the Financial Times this month that he supported term limits for NIH directors. “I think there’s too much concentration of power in the hands of too few people: there should not be another Tony Fauci,” he said.

    Kennedy’s nomination as Health and Human Services secretary has worried the pharmaceutical industry and public health bodies because of his sceptical views on vaccines, his stated aim to eliminate “entire departments” within the FDA and his plans to remove fluoride from drinking water. However, Kennedy has promised not to limit vaccine access.

    In an article on digital media site UnHerd published last week, Bhattacharya brushed away concerns about some of Kennedy’s debunked claims, saying: “Kennedy is not a scientist, but his good-faith calls for better research and more debate are echoed by many Americans.”

    He added that “the American public voted for disrupters like RFK Jr in 2024, and academic medicine now has an opportunity to atone for its Covid-era blunders.”

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Press Room

    Related Posts

    Rheinmetall investors to get bumper dividend from booming arms sales

    March 11, 2026

    How to fight deepfakes

    March 11, 2026

    Best Employers: UK

    March 11, 2026
    Leave A Reply Cancel Reply

    LATEST NEWS

    Australia slips into unexpected AUD 3.02B trade deficit as exports tum

    July 2, 2026

    Base44 CEO Says the Company Built Its Own LLM to Combat AI-Slop Design

    July 2, 2026

    Franklin Covey forecasts FY2026 revenue of $260M-$267M while maintaining adjusted EBITDA of $28M-$31M (NYSE:FC)

    July 2, 2026

    Vinton Cerf Says AI Must Learn These 3 Lessons

    July 2, 2026
    POPULAR
    Business

    The Business of Formula One

    May 27, 2023
    Business

    Weddings and divorce: the scourge of investment returns

    May 27, 2023
    Business

    How F1 found a secret fuel to accelerate media rights growth

    May 27, 2023
    Advertisement
    Load WordPress Sites in as fast as 37ms!

    Archives

    • July 2026
    • June 2026
    • May 2026
    • April 2026
    • March 2026
    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • September 2023
    • May 2023

    Categories

    • Business
    • Crypto
    • Economy
    • Forex
    • Futures & Commodities
    • Investing
    • Market Data
    • Money
    • News
    • Personal Finance
    • Politics
    • Stocks
    • Technology

    Your source for the serious news. This demo is crafted specifically to exhibit the use of the theme as a news site. Visit our main page for more demos.

    We're social. Connect with us:

    Facebook X (Twitter) Instagram Pinterest YouTube

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    Facebook X (Twitter) Instagram Pinterest
    • Home
    • Buy Now
    © 2026 ThemeSphere. Designed by ThemeSphere.

    Type above and press Enter to search. Press Esc to cancel.